I AM ALS

ACT for ALS Reauthorized: Up to $500M for Research and Access

Image
ACT for ALS Reauthorized: Up to $500M for Research and Access

WASHINGTON – November 03, 2026 -- The President has signed the ACT for ALS reauthorization bill into law, extending the program for five years and committing up to an additional $500 million to ALS research infrastructure and investigational treatment access, according to patient advocacy group I AM ALS.

Senate passes bill by unanimous consent hours before the law expires

The Senate approved the reauthorization by unanimous consent with only hours left before the existing law lapsed. The House had already gone home early. The original ACT for ALS Act was co-authored by I AM ALS in 2021 to close a gap in access to investigational treatments.

Sponsors of the reauthorization are Senators Coons (D-DE) and Murkowski (R-AK) and Representatives Quigley (D-IL-05) and Calvert (R-CA-41). Calvert co-chairs the bipartisan ALS Caucus.

I AM ALS Delivers 20,100+ Signatures to Save ACT for ALS Law

Washington – September 19, 2026 -- More than 20,100 Americans signed a petition in just four days demanding Congress reauthorize the Accelerating Access to Critical Therapies (ACT) for ALS law before its September 19, 2026 expiration date.

Petition drive targets key congressional committees ahead of deadline

The campaign, organized by advocacy group I AM ALS during its annual Week of Impact, directs the petition at Senate HELP Committee and House Energy and Commerce Committee leadership. Signatories include patients living with ALS, caregivers, researchers, and clinicians who rely on programs the law established.